DrugPatentWatch Database Preview
I - Biologic Drug Details
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
Company Disclosures: US Patents for i
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bayer Healthcare Pharms | BETASERON | interferon beta-1b | VIAL; SUBCUTANEOUS | 103471 | 001 | 1993-07-23 | Start Trial | Cetus Corporation (Emeryville, CA) | 2039-03-29 | RX | Orphan | company |
Bayer Healthcare Pharms | BETASERON | interferon beta-1b | VIAL; SUBCUTANEOUS | 103471 | 001 | 1993-07-23 | Start Trial | Cetus Corporation (Emeryville, CA) | 2004-03-28 | RX | Orphan | company |
Bayer Healthcare Pharms | BETASERON | interferon beta-1b | VIAL; SUBCUTANEOUS | 103471 | 001 | 1993-07-23 | Start Trial | Cetus Corporation (Emeryville, CA) | 2003-05-13 | RX | Orphan | company |
Bayer Healthcare Pharms | BETASERON | interferon beta-1b | VIAL; SUBCUTANEOUS | 103471 | 001 | 1993-07-23 | Start Trial | Cetus Corporation (Emeryville, CA) | 2005-04-12 | RX | Orphan | company |
Bayer Healthcare Pharms | BETASERON | interferon beta-1b | VIAL; SUBCUTANEOUS | 103471 | 001 | 1993-07-23 | Start Trial | Cetus Corporation (Emeryville, CA) | 2002-10-19 | RX | Orphan | company |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
Patent Text Search: US Patents for i
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Vidara Therapeutics Research Ltd | ACTIMMUNE | interferon gamma-1b | VIAL; SINGLE-USE | 103836 | 001 | 1999-02-25 | Start Trial | 2033-02-06 | RX | search | ||
Vidara Therapeutics Research Ltd | ACTIMMUNE | interferon gamma-1b | VIAL; SINGLE-USE | 103836 | 001 | 1999-02-25 | Start Trial | First Circle Medical, Inc. (Minneapolis, MN) | 2039-02-26 | RX | search | |
Vidara Therapeutics Research Ltd | ACTIMMUNE | interferon gamma-1b | VIAL; SINGLE-USE | 103836 | 001 | 1999-02-25 | Start Trial | First Circle Medical, Inc. (Minneapolis, MN) | 2039-02-26 | RX | search | |
Vidara Therapeutics Research Ltd | ACTIMMUNE | interferon gamma-1b | VIAL; SINGLE-USE | 103836 | 001 | 1999-02-25 | Start Trial | 2019-09-09 | RX | search | ||
Vidara Therapeutics Research Ltd | ACTIMMUNE | interferon gamma-1b | VIAL; SINGLE-USE | 103836 | 001 | 1999-02-25 | Start Trial | First Circle Medical, Inc. (Minneapolis, MN) | 2039-02-26 | RX | search | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |